Results 261 to 270 of about 499,883 (421)

Maslinic Acid Ameliorates DSS‐Induced Experimental Colitis by Suppressing Th Cell‐Mediated Inflammation via AICD Induction

open access: yesPhytotherapy Research, EarlyView.
This study suggests that maslinic acid treatment protected intestinal mucosa and ameliorated gut inflammation, accompanied with significantly reduced inflammatory cytokines and Th cell infiltration and subset differentiation. In vitro, maslinic acid suppressed Th cell proliferation and differentiation, regulated cell cycle distribution, and decreased ...
Dan Li   +8 more
wiley   +1 more source

Interleukin‐1 receptor type II and inflammatory bowel disease: A Mendelian randomization study

open access: yesRheumatology &Autoimmunity, EarlyView.
This Mendelian Randomization study investigated the association between interleukin‐1 receptor type II (IL‐1RII) and inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC) by utilizing the genome‐wide association studies summary statistics.
Qifan Feng   +7 more
wiley   +1 more source

Concomitant Graves' Disease and Ulcerative Colitis. [PDF]

open access: yesCureus
Webeler P   +2 more
europepmc   +1 more source

Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing

open access: yesSmall, EarlyView.
The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa   +4 more
wiley   +1 more source

Ulcerative Colitis

open access: yesInternational Journal of Clinical Practice, 1958
openaire   +3 more sources

Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens

open access: yesSmall, EarlyView.
This review explores the potential of antimicrobial peptides (AMPs) and nanotechnology for the treatment of gastrointestinal infections. It analyzes bacterial resistance mechanisms, the antimicrobial actions of AMPs, and advances in nanocarriers, such as lipid‐based, polymeric, metallic, and mesoporous silica systems, that enhance peptide protection ...
Christian Shleider Carnero Canales   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy